BioLife revenue jumps 21% to $28.5M
BioLife reported a 21% increase in Q2 2026 revenue to $28.5 million. Additionally, the company announced that Repligen will acquire BioLife for approximately $1.5 billion, with the deal expected to close in Q4 2026.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day